Cancer Gene Therapy Market Size, Share & Trends Report

Cancer Gene Therapy Market (2025 - 2030) Size, Share & Trends Analysis Report By Indication (Large B-Cell Lymphoma, Multiple Myeloma), By Vector Type (Lentivirus, RetroVirus & Gamma RetroVirus, AAV), By Route Of Administration, By Region, And Segment Forecasts

Market Segmentation

Cancer Gene Therapy Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Large B-Cell Lymphoma
- Multiple Myeloma
- Acute Lymphoblastic Leukemia (ALL)
- Melanoma (lesions)
- Others
Cancer Gene Therapy Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Intravenous
- Others
Cancer Gene Therapy Vector Type Outlook (Revenue, USD Million, 2018 - 2030)
- Lentivirus
- RetroVirus & gamma RetroVirus
- AAV
- Modified Herpes Simplex Virus
- Adenovirus
- Others
Cancer Gene Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Cancer Gene Therapy Market, by Indication
    - Large B-Cell Lymphoma
    - Multiple Myeloma
    - Acute Lymphoblastic Leukemia (ALL)
    - Melanoma (lesions)
    - Others
  - North America Cancer Gene Therapy Market, by Route of Administration
    - Intravenous
    - Others
  - North America Cancer Gene Therapy Market, by Vector Type
    - Lentivirus
    - RetroVirus & gamma RetroVirus
    - AAV
    - Modified Herpes Simplex Virus
    - Adenovirus
    - Others
  - U.S.
    - U.S. Cancer Gene Therapy Market, by Indication
      - Large B-Cell Lymphoma
      - Multiple Myeloma
      - Acute Lymphoblastic Leukemia (ALL)
      - Melanoma (lesions)
      - Others
    - U.S. Cancer Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
    - U.S. Cancer Gene Therapy Market, by Vector Type
      - Lentivirus
      - RetroVirus & gamma RetroVirus
      - AAV
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
  - Canada
    - Canada Cancer Gene Therapy Market, by Indication
      - Large B-Cell Lymphoma
      - Multiple Myeloma
      - Acute Lymphoblastic Leukemia (ALL)
      - Melanoma (lesions)
      - Others
    - Canada Cancer Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
    - Canada Cancer Gene Therapy Market, by Vector Type
      - Lentivirus
      - RetroVirus & gamma RetroVirus
      - AAV
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
  - Mexico
    - Mexico Cancer Gene Therapy Market, by Indication
      - Large B-Cell Lymphoma
      - Multiple Myeloma
      - Acute Lymphoblastic Leukemia (ALL)
      - Melanoma (lesions)
      - Others
    - Mexico Cancer Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
    - Mexico Cancer Gene Therapy Market, by Vector Type
      - Lentivirus
      - RetroVirus & gamma RetroVirus
      - AAV
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
- Europe
  - Europe Cancer Gene Therapy Market, by Indication
    - Large B-Cell Lymphoma
    - Multiple Myeloma
    - Acute Lymphoblastic Leukemia (ALL)
    - Melanoma (lesions)
    - Others
  - Europe Cancer Gene Therapy Market, by Route of Administration
    - Intravenous
    - Others
  - Europe Cancer Gene Therapy Market, by Vector Type
    - Lentivirus
    - RetroVirus & gamma RetroVirus
    - AAV
    - Modified Herpes Simplex Virus
    - Adenovirus
    - Others
  - UK
    - UK Cancer Gene Therapy Market, by Indication
      - Large B-Cell Lymphoma
      - Multiple Myeloma
      - Acute Lymphoblastic Leukemia (ALL)
      - Melanoma (lesions)
      - Others
    - UK Cancer Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
    - UK Cancer Gene Therapy Market, by Vector Type
      - Lentivirus
      - RetroVirus & gamma RetroVirus
      - AAV
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
  - Germany
    - Germany Cancer Gene Therapy Market, by Indication
      - Large B-Cell Lymphoma
      - Multiple Myeloma
      - Acute Lymphoblastic Leukemia (ALL)
      - Melanoma (lesions)
      - Others
    - Germany Cancer Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
    - Germany Cancer Gene Therapy Market, by Vector Type
      - Lentivirus
      - RetroVirus & gamma RetroVirus
      - AAV
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
  - Switzerland
    - Switzerland Cancer Gene Therapy Market, by Indication
      - Large B-Cell Lymphoma
      - Multiple Myeloma
      - Acute Lymphoblastic Leukemia (ALL)
      - Melanoma (lesions)
      - Others
    - Switzerland Cancer Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
    - Switzerland Cancer Gene Therapy Market, by Vector Type
      - Lentivirus
      - RetroVirus & gamma RetroVirus
      - AAV
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
- Asia Pacific
  - Asia Pacific Cancer Gene Therapy Market, by Indication
    - Large B-Cell Lymphoma
    - Multiple Myeloma
    - Acute Lymphoblastic Leukemia (ALL)
    - Melanoma (lesions)
    - Others
  - Asia Pacific Cancer Gene Therapy Market, by Route of Administration
    - Intravenous
    - Others
  - Asia Pacific Cancer Gene Therapy Market, by Vector Type
    - Lentivirus
    - RetroVirus & gamma RetroVirus
    - AAV
    - Modified Herpes Simplex Virus
    - Adenovirus
    - Others
  - Japan
    - Japan Cancer Gene Therapy Market, by Indication
      - Large B-Cell Lymphoma
      - Multiple Myeloma
      - Acute Lymphoblastic Leukemia (ALL)
      - Melanoma (lesions)
      - Others
    - Japan Cancer Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
    - Japan Cancer Gene Therapy Market, by Vector Type
      - Lentivirus
      - RetroVirus & gamma RetroVirus
      - AAV
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
  - China
    - China Cancer Gene Therapy Market, by Indication
      - Large B-Cell Lymphoma
      - Multiple Myeloma
      - Acute Lymphoblastic Leukemia (ALL)
      - Melanoma (lesions)
      - Others
    - China Cancer Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
    - China Cancer Gene Therapy Market, by Vector Type
      - Lentivirus
      - RetroVirus & gamma RetroVirus
      - AAV
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
  - South Korea
    - South Korea Cancer Gene Therapy Market, by Indication
      - Large B-Cell Lymphoma
      - Multiple Myeloma
      - Acute Lymphoblastic Leukemia (ALL)
      - Melanoma (lesions)
      - Others
    - South Korea Cancer Gene Therapy Market, by Route of Administration
      - Intravenous
      - Others
    - South Korea Cancer Gene Therapy Market, by Vector Type
      - Lentivirus
      - RetroVirus & gamma RetroVirus
      - AAV
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Others
- Rest of the World
  - Rest of the World Cancer Gene Therapy Market, by Indication
    - Large B-Cell Lymphoma
    - Multiple Myeloma
    - Acute Lymphoblastic Leukemia (ALL)
    - Melanoma (lesions)
    - Others
  - Rest of the World Cancer Gene Therapy Market, by Route of Administration
    - Intravenous
    - Others
  - Rest of the World Cancer Gene Therapy Market, by Vector Type
    - Lentivirus
    - RetroVirus & gamma RetroVirus
    - AAV
    - Modified Herpes Simplex Virus
    - Adenovirus
    - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments